IRIS Accounts Production v24.3.0.553 10079494 Board of Directors Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false Ordinary 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh100794942023-03-31100794942024-03-31100794942023-04-012024-03-31100794942022-03-31100794942022-04-012023-03-31100794942023-03-3110079494ns15:EnglandWales2023-04-012024-03-3110079494ns14:PoundSterling2023-04-012024-03-3110079494ns10:Director12023-04-012024-03-3110079494ns10:Director22023-04-012024-03-3110079494ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3110079494ns10:SmallEntities2023-04-012024-03-3110079494ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3110079494ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3110079494ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3110079494ns10:FullAccounts2023-04-012024-03-3110079494ns10:OrdinaryShareClass12023-04-012024-03-3110079494ns10:OrdinaryShareClass1112023-04-012024-03-3110079494ns10:RegisteredOffice2023-04-012024-03-3110079494ns5:CurrentFinancialInstruments2024-03-3110079494ns5:CurrentFinancialInstruments2023-03-3110079494ns5:Non-currentFinancialInstruments2024-03-3110079494ns5:Non-currentFinancialInstruments2023-03-3110079494ns5:ShareCapital2024-03-3110079494ns5:ShareCapital2023-03-3110079494ns5:SharePremium2024-03-3110079494ns5:SharePremium2023-03-3110079494ns5:RetainedEarningsAccumulatedLosses2024-03-3110079494ns5:RetainedEarningsAccumulatedLosses2023-03-3110079494ns5:MotorVehicles2023-04-012024-03-3110079494ns5:MotorVehicles2024-03-3110079494ns5:CostValuation2023-03-3110079494ns5:DisposalsRepaymentsInvestments2024-03-3110079494ns5:CostValuation2024-03-3110079494ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3110079494ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3110079494ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-03-3110079494ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-03-3110079494ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-03-3110079494ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-03-3110079494ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2024-03-3110079494ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2023-03-3110079494ns10:OrdinaryShareClass12024-03-31
REGISTERED NUMBER: 10079494 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

FOR

BIOLEVEL LIMITED

BIOLEVEL LIMITED (REGISTERED NUMBER: 10079494)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


BIOLEVEL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: Mr L G Berman
Mr D I Robertson





REGISTERED OFFICE: Hillside
Albion Street
Chipping Norton
Oxfordshire
OX7 5BH





BUSINESS ADDRESS: Micklands Hill Farm
Stow Road
Bledington
CHIPPING NORTON
Oxfordshire
OX7 6XH





REGISTERED NUMBER: 10079494 (England and Wales)





ACCOUNTANTS: Bronsens
Chartered Certified Accountants
Hillside
Albion Street
Chipping Norton
Oxfordshire
OX7 5BH

BIOLEVEL LIMITED (REGISTERED NUMBER: 10079494)

BALANCE SHEET
31 MARCH 2024

31.3.24 31.3.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 44,227 -
Investments 5 - 88
44,227 88

CURRENT ASSETS
Stocks 6 2,000 2,000
Debtors 7 1,006,998 294,606
Cash at bank 66,103 73,171
1,075,101 369,777
CREDITORS
Amounts falling due within one year 8 463,631 103,754
NET CURRENT ASSETS 611,470 266,023
TOTAL ASSETS LESS CURRENT
LIABILITIES

655,697

266,111

CREDITORS
Amounts falling due after more than one
year

9

34,166

439,770
NET ASSETS/(LIABILITIES) 621,531 (173,659 )

CAPITAL AND RESERVES
Called up share capital 10 188 171
Share premium 641,516 32,929
Retained earnings (20,173 ) (206,759 )
SHAREHOLDERS' FUNDS 621,531 (173,659 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

BIOLEVEL LIMITED (REGISTERED NUMBER: 10079494)

BALANCE SHEET - continued
31 MARCH 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 December 2024 and were signed on its behalf by:




Mr D I Robertson - Director



Mr L G Berman - Director


BIOLEVEL LIMITED (REGISTERED NUMBER: 10079494)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1. STATUTORY INFORMATION

BioLevel Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Motor vehicles - 25% on reducing balance

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

BIOLEVEL LIMITED (REGISTERED NUMBER: 10079494)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

4. TANGIBLE FIXED ASSETS
Motor
vehicles
£   
COST
Additions 58,970
At 31 March 2024 58,970
DEPRECIATION
Charge for year 14,743
At 31 March 2024 14,743
NET BOOK VALUE
At 31 March 2024 44,227

5. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 April 2023 88
Disposals (88 )
At 31 March 2024 -
NET BOOK VALUE
At 31 March 2024 -
At 31 March 2023 88

6. STOCKS
31.3.24 31.3.23
£    £   
Stocks 2,000 2,000

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade debtors 52,661 256,184
Inter company loan 895,389 6,776
Tax 40,023 20,000
VAT 18,925 11,646
1,006,998 294,606

BIOLEVEL LIMITED (REGISTERED NUMBER: 10079494)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Bank loans and overdrafts 5,000 5,000
Other loans 425,226 -
Trade creditors 2,626 216
Tax 4 -
Social security and other taxes 19,615 20,707
Directors' current accounts 8,044 75,045
Accrued expenses 3,116 2,786
463,631 103,754

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.24 31.3.23
£    £   
Bank loans - 1-2 years 5,000 5,000
Bank loans - 2-5 years 15,000 15,000
Bank loans more 5 yr by instal 14,166 19,166
Other loans - 1-2 years - 400,604
34,166 439,770

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 14,166 19,166

10. CALLED UP SHARE CAPITAL

Allotted and issued:
Number: Class: Nominal 31.3.24 31.3.23
value: £    £   
188 Share capital 1 £1.00 188 171
(31.3.23 - 171
)

17 Ordinary shares of £1.00 were issued during the year for cash of £ 608,604 .

11. RELATED PARTY DISCLOSURES

The director Mr Laurence Berman owns 49.2% of Natural Resources Logistics LLP, a business registered in the U.S.A., which in turn owns 70% of the issued share capital of Biolevel Limited.

During the year a management fee of £217,464 (2023 : £295,473) was paid to Natural Resources Logistics LLP.